Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-018238

CytomX Therapeutics, Inc. · CTMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
TRV GP, LLC
10% Owner
Period of report
Jul 13, 2017
Accepted (ET)
Jul 13, 2017 · 8:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 13, 2017J850,000—D4,320,348D
Common StockF3holding———60,934D
Common StockF4holding———89,292D
Common StockF5holding———74,293D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses